Mycobacterial central venous catheter tunnel infection: A difficult problem

Bone Marrow Transplantation

Volumn 24, Issue 3, 1999, Pages 325-329

  Ward, M S ^a   Lam, K V ^a   Cannell, P K ^a   Herrmann, R P ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Central venous catheter; Hickman line; Infection; M. chelonae; M. haemophilum; Mycobacteria

Indexed keywords

BUSULFAN; CEFOXITIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CASE REPORT; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MYCOBACTERIUM; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM HAEMOPHILUM; PRIORITY JOURNAL; SURGERY;

EID: 0032812689     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701895     Document Type: Article

References (22)

1. Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973; 136: 602-606.
2. Hickman RO, Buckner CD, Clift RA et al. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979; 148: 871-875.
3. Groeger JS, Lucas AB, Thaler HT et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993; 119: 1168-1174.
4. Eastridge BJ, Lefor AT. Complications of indwelling venous access devices in cancer patients. J Clin Oncol 1995; 13: 233-238.
5. Howell PB, Walters PE, Donowitz GR, Farr BM. Risk factors for infection of adult patients with cancer who have tunnelled central venous catheters. Cancer 1995; 75: 1367-1375.
6. Kiehn TE, Armstrong D. Changes in the spectrum of organisms causing bacteraemia and fungaemia in immunocompromised patients due to venous access devices. Eur J Clin Microbiol Infect Dis 1990; 9: 869-872.
7. Roy V, Weisdorf D. Mycobacterial infections following bone marrow transplantantion: a 20 year retrospective review. Bone Marrow Transplant 1997; 19: 467-470.
8. Raad H, Vartivarian S, Khan A, Bodey GP. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis 1991; 13: 1120-1125.
9. Flynn PM, Hooser BV, Gigliotti F. Atypical mycobacterial infections of Hickman catheter exit sites. Pediatr Infect Dis J 1988; 7: 510-513.
10. Holland DJ, Chen SC, Chew WW, Gilbert GL. Mycobacterium neoaurum infection of a Hickman catheter in an immunosuppressed patient. Clin Infect Dis 1994; 18: 1002-1003.
11. Esteban J, Fernández-Roblas R, Roman A et al. Catheterrelated bacteremia due to Mycobacterium aurum in an immuncompromised host. Clin Infect Dis 1998; 26: 496-497.
12. Skiest DJ, Levi ME. Catheter-related bacteremia due to Mycobacterium smegmatis. South Med J 1998; 91: 36-37.
13. Rodgers GL, Mortensen JE, Blecker-Shelly D et al. Two case reports and review of vascular catheter-associated bacteremia caused by nontuberculous Mycobacterium species. Ped Infect Dis J 1996; 15: 260-264.
14. Schelonka RL, Ascher DP, McMahon DP et al. Catheterrelated sepsis caused by Mycobacterium avium complex. Pediatr Infect Dis J 1994; 13: 236-237.
15. Bendush CL. Ototoxicity: clinical considerations and comparative information. In: Whelton A, Neu HC (eds). The Aminoglycosides: Microbiology, Clinical Use and Toxicology. Marcel Dekker: New York, 1982, pp 427-429.
16. Horowitz EA, Sanders Jnr WE. Other mycobacterium species. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. Churchill Livingstone: New York, 1995, pp 2269-2271.
17. Alford RH, Wallace Jnr RJ. Antimycobacterial agents. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. Churchill Livingstone: New York, 1995, pp 395-397.
18. Woods GL, Washington JA. Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis 1987; 9: 275-294.
19. Kristjansson M, Bieluch VM, Byeff PD. Mycobacterium haemophilum infection in immunocompromised patients: case report and review of the literature. Rev Infect Dis 1991; 13: 906-910.
20. Straus WL, Ostroff SM, Jernigan DB et al. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med 1994; 120: 118-125.
21. Saubolle MA, Kiehn TE, White MH et al. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev 1996; 9: 435-447.
22. White MH, Papadopoulos EB, Small TN et al. Mycobacterium haemophilum infections in bone marrow transplant recipients. Transplantation 1995; 60: 957-960.